Esperion’s stock tumbles after disclosing dispute about milestone payment
Shares of Esperion Therapeutics Inc. ESPR plunged about 56% in premarket trading on Thursday, the day after the company told…
2,373€
1,89%
Echtzeit-Aktienkurs Esperion Therapeutics Inc.
Bid:
Ask:
Nachrichten zur Esperion Therapeutics Inc. Aktie
Esperion Therapeutics falls 55% in dustup with Daiichi Sankyo over milestone payments
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Esperion Therapeutics, For: Mar 15
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Esperion Therapeutics, For: Mar 10
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Esperion upgraded at Credit Suisse despite selloff after Nexletol data
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Pre-market Movers: Kala Pharmaceuticals, Esperion Therapeutics, Azul, Armata Pharmaceuticals, Biomea Fusion
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - The following are some of the stocks making big moves in Mondays pre-market trading (as of 07.35…
Esperion Therapeutics stock slumps 22% premarket as data from study of cholestrol-lowering drug fail to impress investors
The stock of Esperion Therapeutics Inc. ESPR slumped 22% in premarket trade Monday, as investors seemed to question whether data…
Esperion Launches New Scientific Website
Designed Specifically for the Scientific and Medical Communities, esperionscience.com Features Information about Esperions Landmark CLEAR Outcomes Study, Company Pipeline and…
CLEAR Outcomes Company Update Call: Detailed Results Discussion
ANN ARBOR, Mich., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will host a…
Esperion Therapeutics (ESPR) Reports Q4 Loss, Misses Revenue Estimates
Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of 12.64% and 5.75%, respectively, for the quarter ended December 2022. Do…
Form 10-K Esperion Therapeutics, For: Dec 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Esperion Therapeutics, For: Feb 21
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Esperion Therapeutics Q4 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Esperion Announces Positive CLEAR Outcomes Results To Be Presented as Late-Breaking Clinical Trial at ACC.23/WCC
– NEXLETOL® (bempedoic acid) is the first ATP citrate lyase inhibitor and first oral non-statin to meet the major adverse…
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANN ARBOR, Mich., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that, on February 13,…
Insiderhandel: General Counsel verkauft Aktien von Esperion Therapeutics im Wert von 44.404$
Looker, Benjamin - Vorstand - Tag der Transaktion: 2023-01-18...…
Form 8-K Esperion Therapeutics, For: Jan 08
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Esperion sees preliminary Q4 U.S. net product revenue $14.4M-$15.1M
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Esperion Outlines Upcoming Milestones and Announces Preliminary Fourth Quarter 2022 Financial Results
– Based on the robustness of the CLEAR Outcomes data across primary and secondary endpoints, Company anticipates global regulatory submissions…
Has CTI BioPharma (CTIC) Outpaced Other Medical Stocks This Year?
Here is how CTI BioPharma (CTIC) and Esperion Therapeutics (ESPR) have performed compared to their sector so far this year....…
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANN ARBOR, Mich., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that, on December 9,…
Is Esperion Therapeutics (ESPR) Outperforming Other Medical Stocks This Year?
Here is how Esperion Therapeutics (ESPR) and TransMedics (TMDX) have performed compared to their sector so far this year....…
Esperion (ESPR) Reports Positive Data From CLEAR Study
Esperion (ESPR) announces positive data from the CLEAR Outcomes study, which further strengthens the clinical evidence supporting the role of…
Esperion Nexletol helps cut cardiovascular events in phase 3 trial
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Esperion Announces CLEAR Cardiovascular Outcomes Trial of NEXLETOL® (bempedoic acid) Meets Primary Endpoint
– Demonstrates statistically significant and clinically meaningful results –...…
Why Is Esperion Therapeutics (ESPR) Down 16.7% Since Last Earnings Report?
Esperion Therapeutics (ESPR) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…
Ben Halladay appointed CFO of Esperion
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Esperion Therapeutics Promotes Ben Halladay to Finance Chief
Esperion Therapeutics Promotes Ben Halladay to Finance Chief...…
Esperion to Participate in Jefferies London Healthcare Conference
ANN ARBOR, Mich., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that President and CEO,…
Esperion Therapeutics (ESPR) Reports Q3 Loss, Misses Revenue Estimates
Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of 12.90% and 4.30%, respectively, for the quarter ended September 2022. Do…
Form 10-Q Esperion Therapeutics, For: Sep 30
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Esperion Therapeutics, For: Nov 01
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Esperion Reports Third Quarter 2022 Financial Results and Provides Company Update
– CLEAR Outcomes Trial Achieved Last Patient Last Visit in October Ensuring Timely Trial Completion –...…
Esperion Therapeutics Q3 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Insiderhandel: Chief Medical Officer verkauft Aktien von Esperion Therapeutics im Wert von 7.242$
Foody, Joanne M. - Vorstand - Tag der Transaktion: 2022-10-18...…
Insiderhandel: Chief Commercial Officer verkauft Aktien von Esperion Therapeutics im Wert von 823$
Warren, Eric - Vorstand - Tag der Transaktion: 2022-10-18...…
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ANN ARBOR, Mich., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that, on October 18,…
Esperion Therapeutics (ESPR) Moves 6.5% Higher: Will This Strength Last?
Esperion Therapeutics (ESPR) saw its shares surge in the last session with trading volume being higher than average. The latest…